Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | FSK | BEN |
|---|---|---|
| Price | $10.99 | $32.88 |
| Change today | ▲ 0.18% | ▲ 0.21% |
| Market cap | $3.04B | $16.71B |
| Return, 3 months | +9.2% | -3.3% |
| Return, year to date | -15.9% | +42.4% |
| Return, 1 year | -11.2% | +48.8% |
| P/E (TTM) | -8.2 | 22.4 |
| P/B | 0.6 | 1.4 |
| P/E percentile vs own 5y | – | 63rd |
| Dividend yield | 20.93% | 3.98% |
| Revenue growth (YoY, latest qtr) | – | +14.3% |
| Net profit growth (YoY) | – | +118.8% |
| Gross margin | – | 81.2% |
| Operating margin | – | 14.0% |
| Net margin | – | 8.1% |
| Return on equity | – | 6.3% |
| Analyst target vs. price | +6.9% | +11.2% |
| Analyst buy share | 0% | 30% |
| RSI (14) | 40 | 50 |
| 30-day volatility | 19.4% | 21.2% |
| Max drawdown, 1 year | -35.9% | -19.2% |
| Trend read | Leaning bearish | Leaning bullish |
| Analyst consensus | Hold | Hold |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
